Journal article

Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri(R) Observational Program (TOP)

Helmut Butzkueven, Maria Trojano, Ludwig Kappos, Tim Spelman, Heinz Wiendl, Karen Rosales, Ray Su, Stephanie Licata, Pei-Ran Ho, Nolan Campbell

Multiple Sclerosis Journal | SAGE PUBLICATIONS LTD | Published : 2020